Objectives: To evaluate periconceptional maternal biochemical and hematological parameters and vitamin profiles in relation to the risk of early pregnancy loss and birth weight. Design: Prospective longitudinal study. Setting: University Medical Centre Nijmegen, Academic Medical Centre, Amsterdam, Maria and Elisabeth Hospitals, Tilburg, and Catharina Hospital, Eindhoven, The Netherlands. Subjects: A cohort of 240 women recruited before pregnancy. Interventions: Blood samples were taken preconceptional and at 6 and 10 weeks amenorrhea in which the concentrations of hemoglobin, hematocrit, creatinin, uric acid, total protein, serum iron, total iron-binding capacity, ferritin, and the concentrations of retinol, tocopherol, thiamine, riboflavin, pyridoxal-5 0 -phosphate, cobalamin and folate were analyzed. Main outcome measures: Risk of early pregnancy loss and birth weight. Results: The risk of early pregnancy loss increased with increasing prepregnancy weight, and when the periconceptional decline in hematocrit, creatinin and uric acid was less profound (slope: Po0.01). Maternal smoking was negatively associated with birth weight (mean reduction of 183 g, Po0.05). Maternal age and prepregnancy weight were positively associated with birth weight (Po0.01). No significant associations were found between vitamin concentrations and risk of early pregnancy loss or birth weight. Conclusions: Several periconceptional biochemical parameters are significantly associated with early pregnancy loss. The effects of maternal periconceptional health on embryonic development and subsequent pregnancy outcome should be further explored.
Introduction
The developing embryo and fetus, dependent on maternal nutrient transfer throughout pregnancy, is particularly susceptible to unfavorable maternal conditions in the periconceptional period. During this critical stage of pregnancy, the fertilized ovum increases in mass 2.5 million times and organogenesis and placentation take place. Although the underlying mechanisms, including the role of maternal nutrition and other factors that ultimately result in normal or adverse pregnancy outcome are not yet understood, an adequate periconceptional maternal nutritional status is considered of key importance.
Biochemical measurements in blood are considered to be an objective assessment of nutritional status. The relation between a poor maternal folate status and the risk of delivering a child with a neural tube defect (SteegersTheunissen et al, 1993) and the reported association between maternal anemia and the risk for preterm delivery (Murphy et al, 1986) support the association between suboptimal maternal nutrition and poor pregnancy outcome. The impact of a low prepregnancy weight as proxy for poor maternal nutritional status on birth weight has also been documented (Kramer, 1987; Thame et al, 1997) .
Whether marginal difference in maternal periconceptional vitamin profiles, in biochemical and in hematological parameters, have an effect on pregnancy outcome is unclear. The aim of this longitudinal study was to investigate these markers of maternal metabolism and nutritional status in relation to early pregnancy loss, the most common adverse outcome of pregnancy (Kline et al, 1989) , and birth weight, in a preconceptionally recruited cohort of women.
Methods
Between 1987 and 1990, women were recruited before pregnancy through announcements by the project coordinator. The first monitored pregnancy of 253 women out of 404 preconceptionally recruited nonpregnant women was included for this evaluation. Three women with a twin pregnancy were excluded and 10 women were excluded because of abnormal pregnancy outcome, that is, birth weight below the 2.3 percentile of the Dutch birth weight curve (Kloosterman, 1970) , preterm delivery (o37 weeks gestation), post-term birth (442 weeks gestation), or intrauterine fetal death. This resulted in the evaluation of 240 women, comprising 119 epileptics (99 of which were taking antiepileptic drugs), 15 women who had previously delivered a child with a neural tube defect, and 106 controls. None of the women were under treatment for any infectious, endocrine, metabolic or malignant disease. Part of this cohort of women has been described in detail previously (Steegers-Theunissen et al, 1994; Cikot et al, 2001) . The study by Steegers-Theunissen et al excluded the 15 women who previously delivered a child with a neural tube defect and Cikot et al included only 102 nulliparous control women with an uneventful, singleton pregnancy and normal outcome. The study was carried out in collaboration with five hospitals in The Netherlands: University Medical Centre Nijmegen; Academic Medical Centre, Amsterdam; Catharina Hospital, Eindhoven; and Maria and Elisabeth Hospital, Tilburg. The Medical Ethical Committee of the University Medical Centre Nijmegen, The Netherlands, approved the protocol.
After informed consent was obtained, a research nurse visited the participants at home at obtain a medical history and socioeconomic data, to measure weight and length, and to collect blood samples. Venous blood samples were drawn for the analysis of hemoglobin, hematocrit, creatinin, uric acid, total protein, serum iron, total iron-binding capacity (TIBC), ferritin, retinol, tocopherol, thiamine, riboflavin, pyridoxal-5 0 -phosphate, cobalamin and folate concentrations. The research nurse visited women again who were not pregnant within 6 months to obtain new preconceptional blood samples. A monoclonal antibody-based pregnancy test, menstrual history, and a basal body temperature charting confirmed pregnancy. One or two transvaginal ultrasonographic examinations before the 8th week of gestation were performed to eventually adjust for the duration of the pregnancy. Blood sampling took place again at 6 and 10 weeks amenorrhea. Measurements of birth weight of the newborns were noted from medical records. Early pregnancy loss was defined as a spontaneous abortion ending before or at 16 weeks amenorrhea.
Analytical procedures
Full details of the laboratory procedures used to determine concentrations of retinol (vitamin A), tocopherol (vitamin E), thiamine (vitamin B 1 ), riboflavin (vitamin B 2 ), pyridoxal-5 0 -phosphate (vitamin B 6 ), cobalamin (vitamin B 12 ) and folate have been described elsewhere (Cikot et al, 2001) .
In brief, serum retinol concentrations were determined by high-performance liquid chromatography (HPLC), with fluorescence excitation and emission wavelengths of 348 and 470 nm, respectively. The minimum detectable concentration was 0.06 mmol/l. Precision of the assay in terms of intra-and interassay coefficients of variation (CV) for means of duplicate measurements (at a mean concentration of 0.96 mmol/l) were 1.1 and 5.3%, respectively. Likewise, tocopherol concentrations were determined in serum by HPLC with fluorescence detection. The fluorescence excitation and emission wavelengths were 295 and 390 nm, and the minimum detectable concentration was 0.40 mmol/l. The intra-assay CV was 2.8% (10 replicate determinations, mean concentration 22.2 mmol/l) and the interassay CV was 6.6% (13 simultaneous assay runs, mean concentration 23.7 mmol/l).
Plasma thiamine concentrations were determined by reversed-phase ion-pair HPLC on C18-coated silica, using an n-octanesulfonate containing mobile phase methanolaqueous citrate buffer with a pH of 4.0 (45:55, v/v) . Thiamine was oxidized to thiochrome by K 3 Fe(CN) 6 , and detected by fluorometry with excitation and emission wavelengths of 364 and 462 nm, respectively. The detection limit was 2.3 nmol/l, with an intra-and interassay CV (mean concentration 123 nmol/l) of 4.8 and 6.8%. Riboflavin was determined in heparinized plasma by HPLC with fluorescence detection. Fluorescence excitation and emission wavelengths were 470 and 520 nm. The minimum detectable concentration of this procedure was 10 nmol/l and the intraand interassay CV (duplicate measurements) were 3.9 and 8.2% at a mean concentration of 90 nmol/l. Pyridoxal-5 0 -phosphate was measured in whole blood by HPLC and fluorescence detection determined by excitation and emission wavelengths of 367 and 478 nm. The minimum detectable concentration was 2 nmol. Precision of the technique in terms of intra-assay CV was 1.6% (20 replicate measurements, mean concentration 52 nmol/l) and interassay CV was 5.5% (15 determinations on several days, mean concentration 53 nmol/l).
Cobalamin and folate concentrations in serum were determined simultaneously with the Dual Count solid phase boil (SPB) Radioassay (Diagnostic Products Corporation, Los Angeles, CA, USA). Folate was also determined in erythrocytes. The assay uses a dual label tracer solution ( 57 Covitamin B 12 and 125 I-folic acid) and a suspension of the solid phase binders for vitamin B 12 and folate. The intra-and interassay CV for means of duplicate determinations was o5 and 10% for both vitamins. Hemoglobin (cyanid method), hematocrit (derived value), creatinin (Jaffé method without deproteination), uric acid (uricase/-catalase reaction), total protein (biurete), serum iron (guanidine/ferrozine), TIBC (ibid total iron) and ferritin (sandwich-type immunoenzumetric assay; Tandem-E, Hybritech) were determined by standard methods (Steegers et al, 1999) .
Statistics
Exploratory statistical analyses were performed. Using the data derived from the blood samples, a linear relationship between the logarithm of each biochemical parameter and time of blood sampling (preconceptional, and at 6 and 10 weeks amenorrhea) per woman was fitted, after which an individual slope and intercept was calculated for all participants. For preconceptional values, amenorrhea was set equal to zero. These computations were done using the SASprocedure MIXED. Stepwise logistic and linear regression analysis was applied for the dependent outcomes, early pregnancy loss and birth weight, respectively. Independent variables were the calculated individual intercepts and slopes of the biochemical determinants, as well as maternal age, prepregnancy weight, body mass index (BMI), weight gain until 32 weeks amenorrhea, parity, obstetric and gynecologic history, epilepsy and use of antiepileptic drugs, other medication, education, vitamin supplement use and smoking. The BMI was calculated as the weight in kilograms divided by the square of the height in meters. Criteria for inclusion and exclusion in the regression equations were set at P ¼ 0.10. Final logistic and linear regression equations were computed with, as independent variables, those found in the stepwise procedures. In testing, statistical significance was defined as Po0.05.
Results
Preconceptional blood samples were available for 116 women (48%), blood samples at 6 weeks amenorrhea for 229 women (95%), and 10 weeks amenorrhea for 187 women (78%). The longest interval between preconceptional blood sampling and pregnancy was 13 weeks. The research nurse performed preconceptionally standardized measurements of the weights of 185 women (77%).
The study population (n ¼ 240) was between 19 and 42 years of age. Demographic characteristics, presented in Table 1 , did not significantly differ between women with normal pregnancy outcome (n ¼ 194) and those with early pregnancy loss (n ¼ 46). As this study was carried out before large-scale campaigns on periconceptional folic acid supplement use for the prevention of neural tube defects were performed, most women in our cohort reported not to be taking any vitamin or food supplements in the study period at any moment. Less than 10% of the participants used folic acid or another vitamin supplement. All women but one were Caucasian. In Table 2 , the hematological and biochemical parameters and vitamin profiles measured precconceptionally and at 6 and 10 weeks amenorrhea are presented as median concentrations and 25th and 75th quartiles for women with normal pregnancy outcome and women with early pregnancy loss. Overall, the median values of the two subpopulations are comparable for all parameters and fall within the reference ranges (Steegers et al, 1999; Cikot et al, 2001) .
The intercepts of the hematological values were not significantly associated with birth weight or early pregnancy loss. The risk of early pregnancy loss, however, significantly increased when the physiological decline in hematocrit concentrations in the first trimester of pregnancy was less profound (P-value for slope: r0.01 in the logistic regression, Figure 1a -c. No significant association was found between the course of periconceptional hemoglobin, ferritin, TIBC and iron concentrations and early pregnancy loss, or between the slope of any hematological parameter and birth weight. The probability of early pregnancy loss increased with a diminished first trimester physiological decline in uric acid concentration (Pr0.01), as well as with a diminished decline in ceratinin concentration (Pr0.01). Periconcep- tional total protein concentrations did not affect the risk for early pregnancy loss or birth weight. The preconceptional levels and first trimester changes in the concentrations of retinol, tocopherol, thiamine, riboflavin, pyridoxal-5 0 -phosphate, cobalamin, red cell and serum folate were unrelated to early pregnancy loss and birth weight.
Other factors
Smoking was reported by approximately one-fourth of all women during the study period (Table 1) and was significantly negatively associated with birth weight, with a mean reduction of 183 g in babies born to smoking mothers loss (Pr0.05). Prepregnancy weight was positively related to the risk of early pregnancy loss (Pr0.05) as well as to birth weight (Pr0.01; partial r 2 ¼ 0.24). Prepregnancy BMI and weight gain during pregnancy, measured as the difference in weight at 6 weeks and 32 weeks amenorrhea, were not associated with birth weight. Maternal age was significantly positively related to birth weight (Pr0.01; partial r 2 ¼ 0.26).
Parity, educational background, epilepsy or use of antiepileptic drugs, other medication use or the use of vitamin supplements were not significantly associated with the risk of early pregnancy loss or birth weight.
Discussion
This is the first longitudinal study initiated before pregnancy in which a wide spectrum of maternal biochemical parameters and vitamin profiles in relation to early pregnancy loss and birth weight are evaluated. In this population, we demonstrated that maternal periconceptional vitamin profiles were not significantly associated with the risk of early pregnancy loss or birth weight. Other studies in which vitamin profiles and other maternal parameters are considered in relation to outcome have been initiated during pregnancy and after the periconceptional period (Kramer, 1987) . In terms of effect on intrauterine growth, Kramer (1987) concluded that for protein status, folic acid, vitamins B 6 and B 12 , the causal effect was unlikely, but evidence was insufficient to rule out. Other vitamins, including thiamine, riboflavin, niacin, and the vitamins A, C, and E, received the rating of an uncertain causal effect. However, due to the small effect magnitude and low prevalence, the importance was regarded unlikely. Tamura et al (1997) evaluated various laboratory measurements collected at 18 and 30 weeks of gestation in relation to birth weight. The authors did not find a significant association between vitamins A, E, proteins and birth weight, but reported a positive correlation between maternal serum folate and birth weight of their babies. They did not, however, determine red cell folate levels, a much more reliable reflection of the long-term folate status than serum folate (Bailey, 2000) . Açkurt et al (1995) assessed nutritional status biochemically among Turkish women between 13-17 weeks gestation, 28-32 weeks gestation, and 13-17 weeks postpartum. In their evaluation of maternal blood concentrations, no significant correlation between vitamins A, B 2 , B 6 , B 12 , folate or any hematological or biochemical parameter, that is, ferritin, hematocrit, albumin, and birth weight was found. In a recent review on maternal nutrition and fetal growth, Osrin and Costello (2000) focused on maternal malnutrition and possible interventions, especially in developing countries. They concluded that the effect of micronutrients on fetal growth is difficult to clarify, and that although correction of vitamin profiles among women with deficiencies could be beneficial in many ways, the effects on fetal growth are not clear. In our study, periconceptional vitamin profiles were not found to be useful markers for predicting birth weight or the risk of early pregnancy loss. This may be explained by our study group consisting of relatively well nourished, that is, not underweight Dutch Caucasian mothers with normal vitamin profiles, and their newborns with a normal birth weight between the 2.3 and 97th percentile. It cannot be excluded that preconceptional evaluation of vitamin status and other hematological and biochemical parameters may be beneficial in specific populations at high risk for underweight newborns or other adverse pregnancy outcome. For example, we diagnosed 52 of 292 women (18%) who attended our clinic for preconception care with an indication for laboratory testing, such as previous obstetric complications, as vitamin deficient (De Weerd et al, 2001) . Presuming that correction of a deficient folate, pyridoxine and/or cobalamin status before conception would be beneficial and might improve pregnancy outcome, all of those women were supplemented and advised to postpone conception until adequate blood vitamin levels were reached. It would be very informative to study the outcome of pregnancy among women with abnormal preconceptional vitamin profiles. However, considering the suggested protective effect of high folate concentrations with respect to neural tube defects (Daly et al, 1997) and recurrent early pregnancy loss (Nelen et al, 2000) , it would be difficult to abstain from supplementation once deficiencies are detected.
Biochemical parameters
Serum creatinin and uric acid concentrations both reflect kidney function, and showed a diminished decline in women with early pregnancy loss. In normal pregnancy, a physiological decline in these and in other parameters, including hematocrit, occurs as a results of hemodilution caused by plasma volume expansion, which can be observed from 6 weeks of gestation (Bernstein et al, 2001) . Inadequate plasma volume expansion has been associated with poor pregnancy outcome. This is especially evident in women with pre-eclampsia (Soffronoff et al, 1977; Silver et al, 1998) , as well as in pregnancies complicated by intrauterine growth retardation (Duvekot et al, 1995) . The diminished decrease in creatinin, uric acid, and hematocrit in the women in our study with early pregnancy loss may also indicate insufficient volume expansion and thereby maladaptation to pregnancy that ultimately results in early pregnancy loss.
Altered production and excretion of uric acid among women with a complicated pregnancy has also been related to the hypothetical function of uric acid as an antioxidant. De Jong et al (1997) found impaired uric acid clearance at 13 weeks gestation, reflected by higher serum uric acid concentrations, among women who developed gestational hypertension and delivered a child small-for-gestational age. They also found uric acid production to be decreased before the development of clinically manifest gestational hypertension and pre-eclampsia, in women both with and without a small-for-gestational age child. When interpreting the diminished decline in uric acid, creatinin and hematocrit concentrations among women who miscarried, several issues need to be addressed. First, we do not know whether some of the mechanisms underlying the development of a hypertensive disorder in pregnancy are similar to those lead to early pregnancy loss. Although the decline in creatinin and uric acid concentrations as wells as in hematocrit was significantly diminished among these women, as compared to those with normal outcome, these differences were not thus prominent that they could be used as a predictor for pregnancy outcome. We cannot be certain whether the reduced decline in these parameters was caused by failure of the pregnancy or vice versa. Moreover, if this were due to insufficient volume expansion, a diminished decline in the other parameters would be expected as well. Finally, hyperhomocysteinemia, a sensitive marker for folate, cobalamin or pyridoxine deficiency (Steegers-Theunissen et al, 1992; Ray & Laskin, 1999) and related genetic risk factors (667 C-T mutation in the MTHFR-gene, Nelen et al, 1997) may play a more prominent role in the occurrence of early pregnancy loss. The relation between these factors and pregnancy outcome was not investigated in the present study.
Other factors
Maternal age appeared to be the strongest predictor for birth weight, even after adjustment for smoking, parity, educational background and prepregnancy weight. This is in contrast to the 12 studies considered by Kramer (1987) , who reported no significant effect of maternal age on birth weight. A very young maternal age (less than 16 years) has been shown to negatively influence birth weight, likely because teenage girls are still growing (Buschman et al, 2001) . Maternal smoking has been shown to reduce birth weight by approximately 200 g, as compared to neonates of mothers who did not smoke (Lincoln, 1986 ). An effect of similar magnitude was demonstrated among smoking mothers in the present study, with a mean reduction in birth weight of 183 g. The observation that lighter women tend to have lighter babies was also found in our study population (Kramer, 1987; James, 1997; Thame et al, 1997; Osrin & Costello, 2000) . In addition to prepregnancy weight, BMI, weight gain during pregnancy, and maternal mid-upper arm circumference have also been positively related to birth weight (James, 1997) . It is clear that pre-pregnancy weight has a significant influence on fetal growth as well as on other outcomes of pregnancy, and that being too light as well as too heavy can both have adverse consequences.
In our cohort of women, a higher maternal weight was related to a higher birth weight, but also increased the risk of early pregnancy loss. To our knowledge, the relation between prepregnancy weight and early pregnancy loss has not been reported before. However, a higher maternal weight has been reported as a risk factor for other adverse outcomes of pregnancy. In a cohort of 167750 women, a higher maternal prepregnancy weight was found to significantly increase the risk of late fetal death (Cnattingius et al, 1998) . Maternal obesity has only been strongly linked to the risk of preeclampsia (Eskenazi et al, 1991; Sibai et al, 1995) . The pathophysiological features suggested to be involved, being increased lipid availability, higher cholesterol and triglyceride levels, insulin resistance, and endothelial dysfunction, may also be related to an increased risk for early pregnancy loss.
We demonstrated for the first time that the periconceptional decline in several biochemical and hematological parameters is diminished in healthy women whose pregnancy ends in a miscarriage. However, this finding should be regarded as exploratory and its clinical applicability remains to be ascertained. Secondly, assuming that blood vitamin concentrations reflect nutritional status, we infer that our study sample was overall well nourished, and that none of the nutritional parameters tested in our study are useful predictors for outcome in an apparently healthy population of Dutch women. Marginal differences in vitamin profiles within the normal range appear to be unrelated to early pregnancy loss or birth weight. Nevertheless, whether the parameters used in this study, as a proxy for maternal nutritional health status, directly reflect their availability at tissue level to the developing embryo and fetus is not clear. Metabolic processes in the placenta or within the mother were not considered. We therefore need to continue to explore the mechanisms that underlie the effects of maternal periconceptional health, including markers of volume expansion and oxidative stress, on embryonic and fetal growth and development in order to clarify their impact on pregnancy outcome.
